Senior insider sale
Chief Financial Officer at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$9.14M
31.64K shares
What this filing means
ESPINOZA OCTAVIO plans to sell 31.64K shares of LIGAND PHARMACEUTICALS INC valued at approximately $9.14M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2026ACC: 0001950047-26-008026
Officer· Chief Financial Officer
Since Mar 2026
31.64K
Shares to sell
$9.14M
Approx. market value
31.64K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/12/2026
31.64KTotal acquired31.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2026 | Exercise of Stock Options Cash | 31.64K | — |
| Total | 31.64K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
31.64K
Market value
$9.14M
8/12/2026
Total
Units
31.64K
Value
$9.14M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2026 | 31.64K | $9.14M | NASDAQ | Planned |
| Total | 31.64K | $9.14M | ||